Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC) Meeting Abstract
| Authors: | Makker, V.; Taylor, M. H.; Aghajanian, C.; Oaknin, A.; Mier, J.; Cohn, A. L.; Romeo, M.; Bratos, R.; Brose, M. S.; DiSimone, C.; Messing, M.; Dutta, L.; Ren, M.; Schmidt, E. V.; Orlowski, R.; McKenzie, J. A.; Gillis, K.; Herraez, A. C. |
| Abstract Title: | Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368302507 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.6083 |
| Notes: | Meeting Abstract: 6083 -- Source: Wos |
